This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.81% per year. These returns cover a period from January 1, 1988 through November 3, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
coronavirus: Archive
How to Invest for the Future Economy
by Tracey Ryniec
We've had the pandemic stock winners and the recovery winners, but what happens next?
SPYNegative Net Change MLHRPositive Net Change VOONegative Net Change CBREPositive Net Change QQQMPositive Net Change
coronavirus stock-performance
Why Novavax (NVAX) Stock Fell 19% on Friday
by Madeleine Johnson
Shares of the biotech firm plunged 19.6% in Friday trading after it delayed U.S. submission for its Covid-19 vaccine for the third time.
NVAXNegative Net Change
biotechs coronavirus vaccines
What's Next For Stocks: 10% Pullback or Rolling Correction?
by Daniel Laboe
The enormous amount of sideline cash is still being put to work, with every marginal dip being bought right back up
GSNegative Net Change VTVNegative Net Change VUGPositive Net Change
coronavirus etfs large-cap tech-stocks
5 Pandemic Earnings All-Stars to Watch
by Tracey Ryniec
These 5 companies haven't missed during the pandemic and have spectacular earnings charts.
AMDPositive Net Change MSFTPositive Net Change VNegative Net Change SBUXNegative Net Change ENPHPositive Net Change
coronavirus earnings
Bull of the Day: Exact Sciences (EXAS)
by Kevin Cook
EPS surprises abound as Cologuard and Precision Oncology grow sales 20% into next year
EXASPositive Net Change ADPTPositive Net Change NVTAPositive Net Change NTRANegative Net Change GHNegative Net Change
cancer coronavirus genetics genomics
Bear of the Day: Inovio Pharmaceuticals (INO)
by Madeleine Johnson
Is it too late to buy this coronavirus vaccine stock?
PFENegative Net Change MRNANegative Net Change INOPositive Net Change ACADNegative Net Change
coronavirus medical pharmaceuticals
Bear of the Day: Quidel (QDEL)
by Kevin Cook
Estimates get slashed another 30% since their Q1 report, driving yoy projections negative into 2022
QDELNegative Net Change
coronavirus medical
Bull Of The Day: Facebook (FB)
by Daniel Laboe
Facebook (FB), the world's most powerful social media platform, is a more attractive investment today than ever before
FBPositive Net Change
advertising coronavirus earnings media tech-stocks
Bull of the Day: National Vision (EYE)
by Kevin Cook
As a nation, optical care needs are rising and re-opening trends are spurring a big catch-up on exams
EYENegative Net Change
coronavirus medical
Bear of the Day: Clorox (CLX)
by Tracey Ryniec
Rising costs are a problem for this former pandemic winner.
CLXNegative Net Change
consumer-discretionary consumer-staples coronavirus
Bear of the Day: Quidel (QDEL)
by Kevin Cook
Rising star in diagnostics had a shot at big cap status with 200% growth on COVID testing that faded
QDELNegative Net Change
coronavirus medical
Best Biotech Stocks & ETFs for mRNA, Gene Editing
by Neena Mishra
Here is what you should know about investing in these life changing technologies.
PFENegative Net Change MRNANegative Net Change TBIONo Net Change IBBNegative Net Change EDITPositive Net Change XBINegative Net Change CRSPNegative Net Change CHNAPositive Net Change BNTXNegative Net Change CVACNegative Net Change
biotechs coronavirus
Bull of the Day: Meridian Bioscience (VIVO)
by Kevin Cook
Delay in FDA approval for latest COVID test hasn't altered growth or value at 3X sales
VIVONegative Net Change HOLXNegative Net Change NVAXNegative Net Change QDELNegative Net Change
biotechs coronavirus medical
One Year Later: Lessons from the Coronavirus Stock Sell-Off
by Tracey Ryniec
What did you do with your investment portfolio when the coronavirus crisis hit in spring of 2020?
PAGPositive Net Change TMNegative Net Change ECNegative Net Change TRTNPositive Net Change PINSPositive Net Change
coronavirus stock-performance stock-price-movement value-stocks
5 Hot Upcoming Earnings Charts
by Tracey Ryniec
Earnings season is winding down over the next 2 weeks but there are still incredible earnings charts still to come.
CTASNegative Net Change ULTANegative Net Change JDNo Net Change DOCUNegative Net Change STNENegative Net Change
coronavirus earnings
Vaccine Miracles: Does JNJ Kill the Profit Path for MRNA and NVAX?
by Kevin Cook
New vaccine entrant gets approval before Novavax, while herd immunity ideas put sales in doubt.
JNJNegative Net Change MRNANegative Net Change NVAXNegative Net Change
biotechs coronavirus pharmaceuticals
5 Pandemic Winner Earnings Charts
by Tracey Ryniec
These 5 companies were beneficiaries of the pandemic economy. But what happens next?
NVDAPositive Net Change MRNANegative Net Change ETSYPositive Net Change SQPositive Net Change ABNBPositive Net Change
coronavirus earnings
Hedge Fund Diaries: Who Was Buying Your Stocks?
by Kevin Cook
SEC 13Fs reveal trades from months ago, but also patterns of long-term bullish behavior.
MRNANegative Net Change GMEPositive Net Change NVAXNegative Net Change SHOPPositive Net Change VXRTPositive Net Change
coronavirus economy stock-performance
Bull of the Day: Meridian Bioscience (VIVO)
by Kevin Cook
Small-cap diagnostics player will grow sales 30%+ to over $335 million on COVID-19 testing and its mutations
VIVONegative Net Change HOLXNegative Net Change QDELNegative Net Change
coronavirus medical
Bear Of The Day: Chico's (CHS)
by Daniel Laboe
This stock is trading far above the most optimistic price targets and I would liquidate any positions that I had in CHS, thanking god that I was able to get such a good price for them
CHSPositive Net Change
apparel coronavirus retail
Biotech Bonanza: COVID Launches Science at Warp Speed
by Kevin Cook
From vaccines to diagnostics, the opportunities in biotechnology are rich for those who do their homework.
HOLXNegative Net Change MRNANegative Net Change VIVONegative Net Change NVAXNegative Net Change AXSMPositive Net Change AVXLNegative Net Change VXRTPositive Net Change SAVAPositive Net Change
biotechs coronavirus pharmaceuticals
Bear of the Day: Illumina (ILMN)
by Kevin Cook
Maker of premier next-gen genomic sequencing technology lowers guidance but shares make new highs
ILMNNegative Net Change EDITPositive Net Change NVTAPositive Net Change ARKKPositive Net Change ARKGNegative Net Change
biotechs coronavirus genetics genomics
Bull of the Day: Meridian Bioscience (VIVO)
by Kevin Cook
Small-cap diagnostics player will grow sales 20%+ to over $310 million on COVID-19 testing and its mutations
VIVONegative Net Change HOLXNegative Net Change QDELNegative Net Change EDITPositive Net Change CRSPNegative Net Change
coronavirus genetics genomics medical
With Vaccine Distribution, What Stocks Do I Buy?
by John Blank
A Forward Looking Market Can Be Beguiling.
GSNegative Net Change SCHWPositive Net Change QDELNegative Net Change
biotechs coronavirus
Moderna Vaccine: The Power of mRNA Technology
by Kevin Cook
Warp speed was just the ticket to launch top COVID-19 vaccines -- and a revolution in medicine
AZNNegative Net Change PFENegative Net Change MRNANegative Net Change IBBNegative Net Change XBINegative Net Change
biotechs coronavirus